Morbid obesity and type 2 diabetes: gastric sleeve or bypass

Morbid obesity, frequently accompanied by metabolic syndrome and type 2 diabetes, does not respond sustainably to conservative treatment. Laparoscopic bariatric surgery is now metabolic surgery: it acts far beyond mechanical volume restriction.

Sleeve gastrectomy and Roux-en-Y gastric bypass reconfigure digestive anatomy and drastically modulate gastrointestinal hormones, the incretins. That hormonal shift induces rapid type 2 diabetes remission, often before weight loss, and allows loss of up to 70% of excess body weight. Bypass is usually preferred with severe reflux or long-standing diabetes.

Short-term risks include staple line leaks, bleeding and thrombosis; long term, patients risk severe vitamin malnutrition (B12, iron, calcium, vitamin D) without lifelong supplementation and blood monitoring. Partial weight regain without habit change is also common, as is the need for ongoing psychological and nutritional support.

Turkey has refined bariatric packages with transfers, interpreters and JCI hospitals, attracting patients from across Europe. Mexico, especially Tijuana, is the bariatric giant for US patients thanks to border convenience, with costs around EUR 4,500. Poland guarantees EU standards at fractional prices. The range is EUR 3,500 to 8,000, with five to eight day stays.

At medviajes we compare accredited hospitals, verify that full pre-operative assessment and twelve-month nutritional follow-up exist, and organise the trip. The indication must be set by a qualified bariatric team.